GESTATIONAL TROPHOBLASTIC NEOPLASIA

Course overview

GESTATIONAL TROPHOBLASTIC DISEASE (GTD) INVOLVES BOTH BENIGN AND MALIGNANT ENTITIES THAT INCLUDE HYDATIDIFORM MOLE (COMPLETE AND PARTIAL), CHORIOCARCINOMA, INVASIVE MOLE, EPITHELIOID TROPHOBLASTIC TUMOR (ETT), AND PLACENTAL SITE TROPHOBLASTIC TUMOR (PSTT). THE LATTER FOUR, KNOWN AS GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN), CAN METASTASIZE AND BE FATAL IF NOT TREATED. THIS ACTIVITY REVIEWS THE ETIOLOGY AND PATHOPHYSIOLOGY OF GTN IN THE CLINICAL SETTING. PARTICIPANTS WILL GAIN INSIGHTS INTO EVIDENCE-BASED DIAGNOSTIC APPROACHES, INCLUDING HISTOPATHOLOGICAL EVALUATION AND IMAGING MODALITIES, TO FACILITATE ACCURATE AND TIMELY DIAGNOSIS. CLINICIANS WILL DELVE INTO THE MULTIDISCIPLINARY MANAGEMENT OF GTN, INCLUDING SURGICAL TECHNIQUES, CHEMOTHERAPY REGIMENS, AND EMERGING TARGETED THERAPIES.THE ACTIVITY ADDRESSES CHALLENGES IN TREATMENT, INCLUDING CONSIDERATIONS FOR FERTILITY PRESERVATION, MANAGING COMPLICATIONS, AND FOLLOW-UP SURVEILLANCE. IT EMPHASIZES PATIENT-CENTERED CARE AND SHARED DECISION-MAKING AND HIGHLIGHTS THE NEED FOR EFFECTIVE COMMUNICATION AND COLLABORATION AMONG THE INTERPROFESSIONAL TEAM TO ACHIEVE OPTIMAL, COMPREHENSIVE CARE FOR PATIENTS WITH GTN.